Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
The disease has similar prevalence across high-income and low- and middle-income nations.
Unexpectedly, liver steatosis was also associated with a greater chance of achieving HBsAg seroclearance.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
Blue Faery’s “Love Your Liver” 28-day video campaign raises awareness of liver cancer and overall liver health.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.